M&As this week: LifeWatch, Align Technology, Southern Anesthesia + Surgical (SAS)

23 February 2017 (Last Updated November 22nd, 2018 11:20)

Healthcare technology provider, LifeWatch, will be acquired by investment firm Aevis Victoria, which will purchase all the publicly held registered shares of the target company.

Healthcare technology provider, LifeWatch, will be acquired by investment firm Aevis Victoria, which will purchase all the publicly held registered shares of the target company.

Aevis offers an exchange value between CHF12.40 ($12.36) and CHF13.60 ($13.56) for each LifeWatch share.

Upon successful closing of the offer, the target company would become an independently managed subsidiary of the acquirer and enable it to reinforce its telemedicine activities.

"Upon successful closing of the offer, the target company would become an independently managed subsidiary of the acquirer."

Align Technology, a manufacturer of orthodontic devices, has announced its intention to acquire its distribution partner, G.L. Dental Couture.

Expected to be completed on 25 February 2017, the deal will provide Align Technology direct access to customers and distribution partners across markets in Russia, Commonwealth of Independent States (CIS), Baltics, Turkey, Monaco, Israel, Cyprus, the Middle East and Africa, enabling it to drive accelerated growth across these markets.

The target company is a distributor of Align Technology's Invisalign system.

In a definitive agreement signed to unite two US-based dental-surgical supply companies, Henry Schein, a dental care products provider, has agreed to acquire Southern Anesthesia + Surgical (SAS), a distributor of anaesthesia and surgical supplies.

The acquisition, which is expected to be closed in Q2 2017, subject to regulatory approvals, will make SAS a part of Henry Schein’s subsidiary, ACE Surgical Supply.